Evidence for more extensive deposits of epitopes of oxidized low density lipoprotein in aortas of young people with elevated serum thiocyanate levels

Atherosclerosis

Volumn 121, Issue 1, 1996, Pages 23-33

  Scanlon, Carrie E Oyer ^a   Berger, Blanche ^a   Malcom, Gray ^a   Wissler, Robert W ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Atherosclerosis; LDL; Serum thiocyanate; Smoking

Indexed keywords

LOW DENSITY LIPOPROTEIN; THIOCYANATE;

ADULT; AGE; AORTA; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; AUTOPSY; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; LIPID OXIDATION; PRIORITY JOURNAL; SMOKING; SUDDEN DEATH;

EID: 0342902619     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/0021-9150(95)05672-6     Document Type: Article

References (24)

1. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol: Modifications of low density lipoprotein that increase its atherogenicity. New Engl J Med 1989;320:914.
2. Palinski W, Rosenfeld ME, Ylä-Herttuala S et al. Low density lipoprotein undergoes oxidative modification in-vivo. Proc Natl Acad Sci USA 1989;86:1372.
3. Boyd HC, Gown AM, Wolfbauer G, Chait A. Direct evidence for a protein recognized by a monoclonal antibody against oxidatively modified LDL in atherosclerotic lesions from Watanabe heritable hyperlipemic rabbit. Am J Pathol 1989;135:815.
4. Haberland ME, Fong D, Cheng L. Malondialdehyde-altered protein occurs in atheroma of Watanabe heritable hyperlipemic rabbits. Science 1988;241:215.
5. Ylä-Herttuala S, Palinski W, Rosenfeld ME et al. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J Clin Invest 1989;84:1086.
6. Rosenfeld ME, Palinski W, Ylä-Herttuala S, Butler S, Witztum JL. Distribution of oxidation specific lipid-protein adducts and apolipoprotein B in atherosclerotic lesions of varying severity from rabbits. Arteriosclerosis 1990;10:336.
7. Stein Y, Stein O. Smoking and coronary heart disease: are lipoproteins the link? Lipid Review 1992;6:9.
8. Duthie GG, Wahle KJ. Smoking, antioxidants, essential fatty acids, and coronary heart disease. Biochem Soc Trans 1990;18:1051.
9. Yokode M, Kita T, Arai H, Kawai C, Narumiya S, Fujiwara M. Cholesteryl ester accumulation in macrophages incubated with low density lipoprotein pre-treated with cigarette smoke extract. Proc Natl Acad Sci USA 1988;85:2344.
10. Harats D, Ben-Naim M, Dabach Y, Hollander G, Stein O, Stein Y. Cigarette smoking renders LDL susceptible to peroxidative modification and enhanced metabolism by macrophages. Atherosclerosis 1989;79:245.
11. PDAY Research Group. Relationship of atherosclerosis in young men to serum lipoprotein cholesterol concentrations and smoking: a preliminary report from the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. J Am Med Assoc 1990;264:3018.
12. Cornhill JF, Herderick EE, Stary HC. Topography of human aortic sudanophilic lesions in blood flow in large arteries: Applications to atherogenesis and clinical medicine. Monogr Atheroscler 1990;15:13.
13. Wissler RW. USA multi-center study of the pathobiology of atherosclerosis in youth. Ann NY Acad Sci 1991;623:26.
14. Strong JP, Oalmann MC, Malcom GT, PDAY Research Group. Pathobiological determinants of atherosclerosis in youth: Rationale, methodology and selected risk factor findings. Cardiovasc Risk Factors 1992;2:22.
15. Strong JP, Oalmann MC, Malcom GT, PDAY Research Group. Atherosclerosis in youth: relationship of risk factors to arterial lesions. In: Lauer RM, Luepker RV and Filer LJ Jr, (eds). Monograph on Prevention of Atherosclerosis and Hypertension Beginning in Youth. Malvern, PA: Lea and Febiger, 1994 13-20.
16. Wissler RW. Quantitative microscopic morphometry of the major components of the atherosclerotic plaque. In: Wissler RW, Bond MG, Mercuri M. Tanganelli P, Weber G and Friedman G. (eds). Atherosclerotic Plaques: Advances in Imaging for Sequential Quantitative Evaluation. New York: Plenum Press 1991;205-212.
17. Wissler RW. New insights into the pathogenesis of atherosclerosis as revealed by PDAY. Atherosclerosis 1994;108(Suppl.):S3.
18. Wissler RW, PDAY Research Group. The special effects of several risk factors on progression of atherosclerosis in young people in the USA. In: Yamamoto A, (ed). Multiple Risk Factors in Cardiovascular Disease. Tokyo: Churchill Livingstone Japan 1994;25-35.
19. Vogt TM, Selvin S, Widdowson G, Hulley SB. Expired air carbon monoxide and serum thiocyanate as objective measures of cigarette exposure. Am J Public Health 1977;37:545.
20. Kornitzer M, Vanhemeldonck A, Bourdoux P, De Backer G. Belgium Heart Disease Prevention Project: comparison of self-reported smoking behaviour with serum thiocyanate concentrations. J Epidemiol Comm Health 1983;37:132.
21. Haley NJ, Axelrad CM, Tilton KA. Validation of self-reported smoking behavior: Biochemical analyses of cotinine and thiocyanate. Am J Public Health 1983;73: 1204.
22. Wissler RW, Vesselinovitch D, Schaffner TJ, Glagov S. Quantitating rhesus monkey atherosclerosis progression and regression with time. In: Gotto Jr AM, Smith LC and Allen B, (eds). Atherosclerosis V (Proc Vth Int Symp), New York: Springer-Verlag 1980;757.
23. Wissler RW, Veselinovitch D, Komatsu A. The contribution of studies of atherosclerotic lesions in young people to future research. Ann NY Acad Sci 1990;598:418.
24. Wissler RW, Komatsu A, Ko C, Kusumi Y, Vesselinovitch D. The cell populations and other components of the atheromatous lesions in young people. In: Hauss WH, Wissler RW, Bauch H-J, (eds). New Aspects of Metabolism and Behavior of Mesenchymal Cells During the Pathogenesis of Atherosclerosis. Opladen: Westdeutscher Verlag, 1991; 49-60.